3 March 2026 - Breckenridge Pharmaceutical Inc, the US subsidiary of Spain-based Towa International, announced on Monday the launch of Pomalidomide Capsules, a generic version of Pomalyst by Celgene (now Bristol Myers Squibb), within the oncology the...
3 March 2026 - Japan-based Ono Pharmaceutical Co Ltd announced on Monday an expansion of its multi-target research collaboration with Canadian biotechnology company Congruence Therapeutics.The expanded collaboration is focused on two clinically valid...
2 March 2026 - Biotechnology company United Therapeutics Corporation (Nasdaq:UTHR) announced on Monday that its long-term pivotal phase 3 ADVANCE OUTCOMES study of ralinepag met the primary endpoint, showing a 55% reduction in the risk of clinical wo...
2 March 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Monday that its Phase III FENhance 1 study in relapsing multiple sclerosis (RMS) met the primary endpoint, showing that fenebrutin...